期刊文献+

大肠埃希菌临床分布及耐药性分析 被引量:11

Clinical distribution and drug resistance of escherichia coli
原文传递
导出
摘要 目的探讨济宁市某医院大肠埃希菌(ECO)的临床分布及对抗菌药物的敏感性,为临床感染的预防和治疗提供理论资料。方法对2008年5月-2009年6月从济宁市某医院临床分离的352株非重复的大肠埃希菌进行体外培养鉴定,采用法国生物梅里埃公司API系统进行大肠埃希菌的生化分析鉴定,测定细菌的最低抑菌浓度(MIC),并按照CLSI 2007年版标准,计算细菌对12种抗菌药物的敏感率、中介率和耐药率。结果 ECO从临床标本中以痰液和脓液标本的检出最常见,均占23.9%,其余依次是尿液、其他分泌物、血液、引流液、其他标本、胆汁,分别占19.3%、18.2%、5.7%、3.4%、3.4%、2.2%;大肠埃希菌对哌拉西林、磺胺甲噁唑/甲氧苄啶、头孢哌酮、头孢曲松有较高的耐药性,耐药率均>70.0%,对亚胺培南、阿米卡星较敏感。结论大肠埃希菌存在比较严重的耐药性,临床应尽早进行细菌培养和对抗菌药物的耐药性监测,以指导临床合理用药。 OBJECTIVE To investigate the distributions and drug resistance of Escherichia coli detected in one hospital of Jining,to provide valuable data for infection prevention and treatment.METHODS API half-automicroscan system was used to carry on the drug resistance analysis.The data on bacterial susceptibility testing from 352 clinical non-repeated strains of E.coli collected from May 2008 to Jun 2009 from First People′s Hospital of Jining was analyzed and the resistance,intermediate and susceptible rates of bacteria to all the 12 kinds of antimicrobial agents were calculated by routine custom dilution MIC method according to the CLSI(2007) guidelines,respectively.RESULTS E.coli was mostly isolated from sputum and sanies,both accounting for 23.9%,the following were urine and various types of secretions,blood,fluid drainage,bile and other specimens,respectively accounting for 19.3%,18.2%,5.7%,3.4%,2.2% and 3.4%.These strains were susceptible only to imipenem and amikacin,and the drug resistant rates to other antibiotics such as piperacillin,cotrimoxazole,cefoperazone and ceftriaxone were all more than 70.0%.CONCLUSION E.coli has high resistance to a lot of antibiotics.Bacterial culture and monitoring to their resistance to antibiotics should be performed early in clinical jobs to guide reasonable drug prescription and control nosocomial infection.
作者 侯桂霞 倪楠
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第11期2337-2339,共3页 Chinese Journal of Nosocomiology
关键词 大肠埃希菌 临床分布 耐药分析 Escherichia coli Clinical distribution Resistance analysis
  • 相关文献

参考文献7

二级参考文献39

共引文献1091

同被引文献75

  • 1蔡玉桂,刘珍才,李志伟,杨雪英,李树裕.特发性血小板减少性紫癜患者医院感染危险因素分析[J].中华医院感染学杂志,2004,14(10):1110-1112. 被引量:2
  • 2卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:80
  • 3许洪志,王建红,刘新,王相华,徐功立.急性白血病医院感染影响因素的病例对照研究[J].山东医药,2006,46(16):7-9. 被引量:4
  • 4Zhu J,Nieto FJ,Horne BD,et al.Prospective study of pathogen burden and risk of myocardial infarction or death[J].Circulation,2001,103(1):45-51.
  • 5Von Hundelshausen P,Weber C.Platelets as immune cells:bridging inflammation and cardiovascular disease[J].Circ Res,2007,100(1):27-40.
  • 6Fowler VG,Miro JM,Hoen B,et al.Staphylococcus aureus endocarditis:a consequence of medical progress[J].JAMA,2005,293(24):3012-3021.
  • 7Fitzgerald JR,Foster TJ,Cox D.The interaction of bacterial pathogens with platelets[J].Nat Rev Microbiol,2006,4(6):445-457.
  • 8Asturias EJ,Corral JE,Quezada J.Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia[J].Curr Oncol,2010,17(2):59-63.
  • 9Dankert J,Van der WJ,Zaat SA,et al.Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis[J].Infect Immun,1995,63(2):663-671.
  • 10Weyrich AS,Zimmerman GA.Platelets:signaling cells in the immune continuum[J].Trends Immunol,2004,25(9):489-495.

引证文献11

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部